ResearcherTokushima UniversityNo recent work listed
Jun Okazaki
Matched on OpenAlex author ID A5042837876. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 2
- MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1159/000503225↗
- A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1007/s00280-015-2835-3↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tetsuji Takayama · 2 shared papers, 2015–2020 · strength 0.13
- Paper MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor … DOI 10.1159/000503225↗
- Paper A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic … DOI 10.1007/s00280-015-2835-3↗
- Masanori Takehara · 2 shared papers, 2015–2020 · strength 0.13
- Paper MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor … DOI 10.1159/000503225↗
- Paper A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic … DOI 10.1007/s00280-015-2835-3↗
- Takahiro Goji · 1 shared paper, 2015 · strength 0.03
- Yasuyuki Okada · 1 shared paper, 2015 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.